MENU

KOD Kodiak Sciences Forecast, Technical & Fundamental Analysis

a developer of novel therapies for the treatment of retinal disease

Industry Biotechnology
KOD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
KOD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

KOD is expected to report earnings to rise 8.27% to -90 cents per share on March 27

Kodiak Sciences KOD Stock Earnings Reports
Q4'24
Est.
$-0.91
Q3'24
Beat
by $0.06
Q2'24
Beat
by $0.01
Q1'24
Beat
by $0.26
Q4'23
Missed
by $0.36
The last earnings report on November 14 showed earnings per share of -83 cents, beating the estimate of -89 cents. With 67.27K shares outstanding, the current market capitalization sits at 466.77M.
A.I. Advisor
published General Information

General Information

a developer of novel therapies for the treatment of retinal disease

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
1200 Page Mill Road
Phone
+1 650 281-0850
Employees
111
Web
https://www.kodiak.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

KOD and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, KOD has been loosely correlated with AKBA. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if KOD jumps, then AKBA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KOD
1D Price
Change %
KOD100%
+9.24%
AKBA - KOD
41%
Loosely correlated
+1.63%
IMNM - KOD
40%
Loosely correlated
-3.38%
MGTX - KOD
39%
Loosely correlated
+1.91%
BEAM - KOD
39%
Loosely correlated
-1.21%
RXRX - KOD
39%
Loosely correlated
-4.30%
More